{"id":"W3019492746","doi":"10.1177/0333102420920642","title":"Assessment of immunogenicity from galcanezumab phase 3 trials in patients with episodic or chronic migraine","year":2020,"lang":"en","type":"article","venue":"Cephalalgia","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Medicine; Immunogenicity; Calcitonin gene-related peptide; Placebo; Antibody; Chronic Migraine; Pharmacokinetics; Internal medicine; Adverse effect; Migraine; Antibody titer; Immunology; Pharmacology; Titer; Pathology; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03275877,0.0004761594,0.001273541,0.0008830202,0.0003934634,0.001306473,0.0004353005,0.0005003564,0.001735007],"category_scores_gemma":[0.0266793,0.0002100921,0.00235777,0.001050009,0.0003399363,0.0007841293,0.000621233,0.0007596022,0.0002626442],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006206091,"about_ca_system_score_gemma":0.0007743642,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002018964,"about_ca_topic_score_gemma":0.0003414254,"domain_scores_codex":[0.987385,0.00737109,0.001979223,0.0007211338,0.002058469,0.0004850438],"domain_scores_gemma":[0.9657746,0.01626972,0.01289902,0.001726334,0.002597556,0.0007328736],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.09413715,0.0009145046,0.716208,0.002756205,0.01440766,0.0005764551,0.0006466374,0.003554478,0.0134227,0.0003869729,0.003435954,0.1495532],"study_design_scores_gemma":[0.007396736,0.04457624,0.9173093,0.0003413003,0.007028205,0.003183661,0.0002000576,0.002717866,0.005641432,0.0004848478,0.0110738,0.00004653363],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9741768,0.01533877,0.002541146,0.0002873415,0.00005423066,0.0008809513,0.001661212,0.00006074478,0.004998884],"genre_scores_gemma":[0.9956776,0.001004509,0.0007257298,0.0003097841,0.00008268386,0.0004707883,0.001468896,0.00001864299,0.0002413296],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03275877,"threshold_uncertainty_score":0.173247,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05335005656755624,"score_gpt":0.359268087055071,"score_spread":0.3059180304875147,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}